In this regard, in tumor bearing mice, NKG2A-silenced cells of the NKL cell line revealed enhanced killing activity of 721.221 HLA-E expressing EBV-LCL tumor cells [151–153]. The gene discussed is KLRC1; the disease is neoplasm.